Literature DB >> 782652

Immunoglobulin synthesis in the "resting" breast.

J O Drife, D B McClelland, A Pryde, M M Roberts, I I Smith.   

Abstract

Nulliparous women have a greater risk of developing breast cancer than women who have borne children, but so far no functional differences in breast tissue have been reported between parous women and nulliparae. Macroscopically and histologically normal breast tissue was obtained from 74 women of reproductive age during biopsy of benign breast lesions and was examined for the presence of plasma cells by immunfluorescence. Immunoglobulin synthesis was detected by an in-vitro culture technique. Synthesis of IgA was detected in 81% of specimans of IgG in 45%, and of IgM in 3%. IgA synthesis much more intense than IgG or IgM synthesis. Plasma cells containing IgA were seen in 71% of the specimens examined, and 88% of specimens had deposits of IgA in the ductules. The findings were not significantly incluenced by the nature of the condition necessitating biopsy or by oral contraception. Nulliparous women showed no cyclical changes, but among parous women IgA synthesis was more intense during luteal phase of the menstrual cycle. This suggests that after the first pregnancy the breast is more sensitive to progesterone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782652      PMCID: PMC1687970          DOI: 10.1136/bmj.2.6034.503

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Changes in breast volume during normal menstrual cycle and after oral contraceptives.

Authors:  D Milligan; J O Drife; R V Short
Journal:  Br Med J       Date:  1975-11-29

2.  Influence of prostaglandins and human chorionic gonadotrophin on progesterone concentration and oocyte maturation in mouse ovarian follicles maintained in organ culture.

Authors:  P Neal; T G Baker; K P McNatty; R J Scaramuzzi
Journal:  J Endocrinol       Date:  1975-04       Impact factor: 4.286

3.  Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique.

Authors:  P Brandtzaeg
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

4.  Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer.

Authors:  P K Siiteri; B E Schwarz; P C MacDonald
Journal:  Gynecol Oncol       Date:  1974-08       Impact factor: 5.482

5.  The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity.

Authors:  R van Furth; R E Schuit; W Hijmans
Journal:  Immunology       Date:  1966-07       Impact factor: 7.397

Review 6.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  Some observations on the measurement of estradiol-17 in human plasma by radioimmunoassay.

Authors:  E H Cameron; D A Jones
Journal:  Steroids       Date:  1972-12       Impact factor: 2.668

8.  Synthesis of immunoglobulin and secretory component by gastrointestinal mucosa in patients with hypogammaglobulinaemia or IgA deficiency.

Authors:  D B McClelland; D J Shearman; R Van Furth
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

Review 9.  Localized humoral immunity with particular reference to ruminants.

Authors:  A K Lascelles; G H McDowell
Journal:  Transplant Rev       Date:  1974
  9 in total
  3 in total

1.  Breast cancer, pregnancy, and the pill.

Authors:  J O Drife
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

2.  Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells.

Authors:  Emiliano Pavoni; Giorgia Monteriù; Daniela Santapaola; Fiorella Petronzelli; Anna Maria Anastasi; Angela Pelliccia; Valeria D'Alessio; Rita De Santis; Olga Minenkova
Journal:  BMC Biotechnol       Date:  2007-10-18       Impact factor: 2.563

3.  Immunological activities of milk.

Authors:  T J Newby; C R Stokes; F J Bourne
Journal:  Vet Immunol Immunopathol       Date:  1982-01       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.